Delivery Order SPE2DR25D3201-SPE2DR26FT4SF
- Not listed
- The Defense Logistics Agency awarded a $3,840 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials on November 17, 2025, with completion expected by November 18, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The performance location is listed as the company's corporate office in...
- The Defense Logistics Agency awarded a $1,344.51 firm fixed price delivery order to AmerisourceBergen Drug Corp for Priorix vials on December 16, 2025, with an ultimate completion date of December 17, 2025. Priorix is a measles, mumps, and rubella (MMR) vaccine commonly used in military and federal healthcare systems. This is a non-set-aside competitive award issued against AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $97,082 delivery order to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of October 21, 2025. This competitive, firm fixed-price contract was issued without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella (MMR) combination vaccine used by military and federal healthcare systems to support immunization requirements across the...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,985.62 for Priorix vials on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella vaccine used to support military and federal healthcare immunization...
- The Defense Logistics Agency awarded a $4,368.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the procurement of Priorix vials, with a completion date of June 25, 2025. This non-set-aside award was competitively issued and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella vaccine commonly used by military and federal healthcare systems to maintain immunization readiness across the Department of Defense....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Priorix vials, valued at $35,329.70. This firm fixed-price delivery order, which is expected to be completed by July 23, 2025, was issued without a set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,059.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of November 25, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. Priorix is a...
- The Defense Logistics Agency awarded a $49,506 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of August 19, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor's Corporate Office division, with performance to take place at the company's headquarters in Conshohocken, Pennsylvania. Priorix is a measles, mumps, and rubella combination vaccine, indicating this delivery supports the Department...
- The Defense Logistics Agency awarded a $1,694.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of September 4, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $14,845.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Priorix vials, with a completion date of June 10, 2025. This is a non-set-aside competitive award executed on June 9, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4SFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,801.10 in Priorix vials, with performance through December 16, 2025. The award, issued on December 15, 2025, represents a firm fixed-price delivery order under a competitive, non-set-aside procurement. Priorix is a combined measles, mumps, and rubella vaccine commonly supplied to military medical facilities and federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency and military healthcare programs. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare operations worldwide. The company's track record of competitive awards and diverse pharmaceutical delivery portfolio demonstrates its established capability to fulfill federal medical supply requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 12/14/25 |